As many biopharma and life sciences companies have experienced a sharp increase in demand for new products and technologies in 2020–2021, our new blog series ‘Challenges of Rapid Growth’ explores common growing pains and provides helpful CQV tips.
The biopharmaceutical industry is in a unique position to address many challenges amid the COVID-19 pandemic.
Holding this position means being ready to meet the demand for quality products is increasing rapidly.
We’ve outlined some ways to keep your facility’s manufacturing on track, meet client demands, and deliver the best quality product the first time, every time.
Five Components to Meet Rapidly Growing Demand
The pandemic has changed the biopharma industry’s ability to respond quickly to deadly viruses. To help support this response, building a solid foundation into your manufacturing will set you up for success.
There are five components to consider when meeting this growing product demand:
While this can be an added advantage, it helps to be skeptical, too. Pharma Manufacturing suggests evaluating a potential partner’s capabilities, utilities, and regulatory history, such as:
- Do they have the right infrastructure in place?
- Will they be able to mobilize quickly?
- Is the partnership likely to produce a safe, consistent product according to regulatory criteria?
Also consider following these tips to reduce the impact on your supply chain.
See our previous post in this series: Expanding Within Your Footprint
How to Maintain Consistency While Expanding Your Operations
So you’ve met your quantity requirements all while preserving quality, but how do you maintain this consistency?
There are always opportunities to improve on quality. After meeting your supply demands, find time to run an assessment with your production team.
For example: What went well? What could have gone better? What would you do differently next time?
Taking time for this type of reflection will ensure continuous process improvements.